Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer’s disease

Manuscript Number: 

12-1474R1

Author(s): 
David Ames, Ashley I. Bush, James D. Doecke, Kathryn A. Ellis, Noel G. Faux, Christopher Fowler, Ralph N. Martins, Colin L. Masters, Kelly Pertile, Alan Rembach, Blaine R. Roberts, Christopher C. Rowe, Rebecca Rumble, Brett Trounson, Victor L. Villemagne, Irene Volitakis, Andrew D. Watt, William Wilson

Disclosures

David Ames

  • Consulting Fees:
    Eli Lilly and Prana and Pfizer
    Lecture Fees:
    Pfizer
    Grants
    • Agency: 
      Prana
      Dates: 
      2012
    • Agency: 
      Pfizer
      Dates: 
      2009-2011
    • Agency: 
      Eli Lilly
      Dates: 
      2010-2012

Ashley I. Bush

  • Consulting Fees:
    Prana Biotechnology Ltd Cthulhu
    Equity:
    Prana Biotechnology Ltd Mesoblast Ltd Cogstate Ltd
    Lecture Fees:
    Amgen
    Patents/Royalties
    Prana Biotechnology Ltd

James D. Doecke

  • Nothing to Disclose

Kathryn A. Ellis

  • Nothing to Disclose

Noel G. Faux

  • Nothing to Disclose

Christopher Fowler

  • Nothing to Disclose

Ralph N. Martins

  • Nothing to Disclose

Colin L. Masters

  • Equity:
    Prana biotechnology

Kelly Pertile

  • Nothing to Disclose

Alan Rembach

  • Nothing to Disclose

Blaine R. Roberts

  • Nothing to Disclose

Christopher C. Rowe

  • Nothing to Disclose

Rebecca Rumble

  • Nothing to Disclose

Brett Trounson

  • Nothing to Disclose

Victor L. Villemagne

  • Nothing to Disclose

Irene Volitakis

  • Nothing to Disclose

Andrew D. Watt

  • Nothing to Disclose

William Wilson

  • Nothing to Disclose